We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck Strikes Licensing Deal With Indian Generics Makers for COVID-19 Antiviral
Merck Strikes Licensing Deal With Indian Generics Makers for COVID-19 Antiviral
Merck has issued licenses to five Indian generic drugmakers to produce its COVID-19 antiviral molnupiravir in a move to expand global access to the drug.